• Our focus
    • Back
    • Our focus
    • Community engagement
    • Understanding brain diseases
      • Migraine awareness
      • Mental health awareness
    • Neurology
      • Alzheimer's Disease
      • Lennox-Gastaut Syndrome
      • Migraine
      • Parkinson's Disease
    • Psychiatry
      • Alcohol Use Disorder
      • Bipolar Disorder
      • Borderline Personality Disorder
      • Depression
      • Generalized Anxiety Disorder
      • Post-Traumatic Stress Disorder
      • Schizophrenia
    • Report a side effect
  • Our science
    • Back
    • Our science
    • Research and development
      • Our value chain
    • Products
    • Pipeline
    • Medical education
      • Lundbeck Institute
    • Clinical trials
      • Clinical trial diversity
      • Study synopses
    • Clinical data sharing
    • Publications
  • Stories
  • Sustainability
    • Back
    • Sustainability
    • ESG Commitments and principles
    • Access to brain health
    • Climate action
    • Donations and grants
    • Health and safety at work
    • Materials use and waste
    • Responsible business conduct
      • Code of Ethics
    • Suppliers and third-parties
    • Transparent interactions
  • About us
    • Back
    • About us
    • Our commitment
      • Inclusion, diversity & equity
      • Our position on Brain Health
      • Our position on Patient Centricity
    • This is Lundbeck
      • At a glance
      • Organization and ownership
      • The Lundbeck Foundation
      • Our history
    • Our leadership
      • Executive Leadership Team
      • Board of Directors
    • Corporate governance
      • Board tasks
      • Remuneration
      • Risk management
  • Code of Ethics
  • Careers
    • Back
    • Careers
    • Life at Lundbeck
      • Our culture and people
      • Building community
      • Employee development
    • Your job
      • Job opportunities
      • Career areas
      • Recruitment process
      • Unsolicited applications
    • Early career programs
      • Students
  • Investors
    • Back
    • Investors
    • Releases
      • Release subscription
    • Financials
    • Reports and presentations
      • Annual Reporting 2025
    • Events
      • Financial calendar and events
      • General meeting
    • Investor Portal
    • The share
      • Share data
      • Shareholders and dividends
      • Analyst coverage
      • New share structure
    • Debt
  • Partnering
    • Back
    • Partnering
    • Partnership initiatives
      • External Research & Innovation
      • Lighthouse Life Science
      • Lundbeck Biotech Incubator
      • HEAD-WINd®
    • Lundbeck CDM
  • Press
  • Contact
  • Other sites (Global)
    • Back
    • Global
      • Back
      • Global site
    • Americas
      • Back
      • Argentina
      • Brazil
      • Canada
      • Chile
      • Colombia
      • Mexico
      • Panama
      • Peru
      • United States
    • Asia
      • Back
      • China
      • Israel
      • Japan
      • Korea
      • Singapore
      • Turkey
    • Europe
      • Back
      • Austria
      • Belgium
      • Bulgaria
      • Czech Republic
      • Denmark
      • Estonia
      • Finland
      • France
      • Germany
      • Greece
      • Ireland
      • Italy
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Slovenia
      • Spain
      • Sweden
      • Switzerland
      • United Kingdom
    • Oceania
      • Back
      • Australia and New Zealand
    • Other Sites
      • Back
      • Drughunters
      • Elaiapharm
      • Lundbeck CDM
      • Lundbeck GBS Krakow
      • Brain Battle
      • Longboard Pharmaceuticals
  1. Home
  • Linkedin
  • Facebook
  • Email
  • Linkedin
  • Facebook
  • Email

Search Results

Dr. Johan Luthman appointed EVP and Head of Research & Development in Lundbeck
Dr. Johan Luthman appointed EVP and Head of Research & Development in Lundbeck
Dr. Johan Luthman udnævnt koncerndirektør for forskning og udvikling hos Lundbeck
Dr. Johan Luthman udnævnt koncerndirektør for forskning og udvikling hos Lundbeck
Lundbeck joins EHDEN
research programme currently in planning.”    Johan Luthman, Executive Vice President, Research & Development, Lundbeck, said, “Joining ...
PowerPoint Presentation
Download
pdf, 13 MB
RD day 2023 London_compiled_FINAL.pdf
Download
pdf, 10 MB
Transcript.pdf
Download
pdf, 246 KB
Q1 2020 teleconference transcript.pdf
Download
pdf, 206 KB
Lundbeck_Transcript - Get Visual_2024-11-13 1300 CET.pdf
Download
pdf, 251 KB
CME 2024_MasterDeck_Presentation Version_vFinal
Download
pdf, 10 MB
Q1-2019-transcript.pdf
Download
pdf, 242 KB
Transcript Lundbeck AS 2023-08-16.pdf
Download
pdf, 271 KB
Q2-2019-transcript.pdf
Download
pdf, 246 KB
Lundbeck FY 2020 results transcript.pdf
Download
pdf, 165 KB
Previous 1 2 3 4 5 6 7 8 9 10 11 Next
Johan Luthman. Executive Vice President, R&D
Johan Luthman. Executive Vice President, R&D
Download
jpg, 1 MB
Johan Luthman, Executive Vice President, R&D
Johan Luthman, Executive Vice President, R&D
Download
jpg, 22 MB
Johan Luthman, Executive Vice President, R&D
Johan Luthman, Executive Vice President, R&D
Download
jpg, 22 MB
Johan Luthman, Executive Vice President, R&D
Johan Luthman, Executive Vice President, R&D
Download
jpg, 26 MB
Johan Luthman, Executive Vice President, R&D
Johan Luthman, Executive Vice President, R&D
Download
jpg, 18 MB
Johan Luthman, Executive Vice President, R&D
Johan Luthman, Executive Vice President, R&D
Download
jpg, 16 MB
Johan Luthman, Executive Vice President, R&D
Johan Luthman, Executive Vice President, R&D
Download
jpg, 17 MB
Johan Luthman.png
Johan Luthman.png
Download
png, 1 MB
Johan-Luthman.jpg
Johan-Luthman.jpg
Download
jpg, 1 MB
Johan_Luthman.jpg
Johan_Luthman.jpg
Download
jpg, 148 KB
1 2 Next

H. Lundbeck A/S

Ottiliavej 9
2500 Valby
Denmark

Headquarters

  • +45 3630 1311
  • info@lundbeck.com

Links

  • Report a side effect
  • Compliance hotline
  • Terms of use
  • Contact us
  • Social media principles
  • Cookie settings

Connect with us

Privacy policy

Copyright© 2026 H. Lundbeck A/S